What is a common treatment for hyperkalemia?

Hyperkalemia, characterized by elevated potassium levels in the blood, can lead to significant complications, including cardiac issues. Common treatments focus on rapidly lowering potassium levels.

Calcium gluconate is often administered to stabilize the cardiac membrane in patients with hyperkalemia, thereby reducing the risk of arrhythmias associated with high potassium levels. Albuterol, a bronchodilator, can also help lower potassium by stimulating the uptake of potassium into cells, although it's not its primary indication. While diuretics and sodium bicarbonate can also contribute to potassium management, they are typically used in different contexts or not as immediate interventions.

The combination of calcium gluconate and albuterol effectively addresses both the immediate cardiac risks and aids in reducing serum potassium levels, making this treatment a well-rounded approach to managing hyperkalemia in an acute setting.